Biosimilars are safe and effective medications for treating many illnesses such as arthritis and cancer. Learn about biosimilars and how they benefit patients.

May 22, 2025 · There have been 75 biosimilars approved by the U.S. Food and Drug Administration (FDA). The most recent biosimilar approval was Starjemza (ustekinumab …

Jan 24, 2023 · Between 2015 and 2022, the FDA approved 40 biosimilar medications. Twenty of them — including four interchangeable biosimilars that your pharmacist can swap for …

A biosimilar, or biosimilar medicine, is a medicine that is very close in structure and function to an existing brand name biologic medicine. The original biologic medicine is known as the …

Sep 22, 2022 · Biosimilars are a class of drugs designed to increase access for patients who need treatment with a biologic medicine.

Since 2015, biosimilar medicines have generated $36 billion in savings and have been used in more than 2.7 billion days of patient therapy with no meaningful differences in clinical …

Apr 22, 2025 · Learn how biosimilars provide lower-cost alternatives to expensive biologic drugs, improving access to life-saving treatments, reducing healthcare costs, and encouraging …

Sep 21, 2020 · Biosimilars bring the same lifesaving treatments to patients battling cancer and other chronic illnesses, such as multiple sclerosis, diabetes, rheumatoid arthritis and Crohn’s …

Mar 13, 2025 · Below is a ranked list of the top ten biosimilars recently approved by the FDA, based on their therapeutic importance and market value. Merilog: Approved in February 2025, …

6 days ago · Pembrolizumab, dupilumab, risankizumab, and adalimumab each illustrate different stages in the biosimilar life cycle, from active market presence to future potential. As …